Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

This study has been completed.

First Received: June 4, 2007 Last Updated: June 2, 2008 History of Changes

Sponsor:	Bispebjerg Hospital
Information provided by:	Bispebjerg Hospital
ClinicalTrials.gov Identifier:	NCT00483145

Purpose

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

Condition	Intervention
Acne Vulgaris and Rosacea	Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Study Type:	Interventional
Study Design:	Randomized, Single Blind, Active Control, Single Group Assignment
Official Title:	Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Resource links provided by NLM:

MedlinePlus related topics: Acne Rosacea

U.S. FDA Resources

Further study details as provided by Bispebjerg Hospital:

Study Start Date:	November 2006
Study Completion Date:	November 2007

Arms	Assigned Interventions
1: Active Comparator Long-pulsed dye laser (Candela)	Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser
2: Active Comparator Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)	Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Inflammatory acne and rosacea
Skin types I-IV

Exclusion Criteria:

Patients younger than 18 years
Skin types V and VI
Topical and systemic conventional acne treatments

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00483145

Locations

Denmark
Bispebjerg Hospital
Copenhagen NV, Denmark, 2400

Sponsors and Collaborators

Bispebjerg Hospital

Investigators

Principal Investigator:

Merete Hædersdal

Bispebjerg Hospital

More Information

No publications provided

Responsible Party:	Bispebjerg Hospital ( Merete Hædersdal )
Study ID Numbers:	KF-01-328309
Study First Received:	June 4, 2007
Last Updated:	June 2, 2008
ClinicalTrials.gov Identifier:	NCT00483145 History of Changes
Health Authority:	Denmark: The Ministry of the Interior and Health

Additional relevant MeSH terms:

Rosacea
Facial Dermatoses
Skin Diseases

Acneiform Eruptions
Sebaceous Gland Diseases
Acne Vulgaris

ClinicalTrials.gov processed this record on November 30, 2009